相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Phosphatidylinositol 4-kinase IIIβ mediates contraction-induced GLUT4 translocation and shows its anti-diabetic action in cardiomyocytes
A. Sun et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2021)
Re-balancing cellular energy substrate metabolism to mend the failing heart
Jan F. C. Glatz et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2020)
Metabolic Remodeling Promotes Cardiac Hypertrophy by Directing Glucose to Aspartate Biosynthesis
Julia Ritterhoff et al.
CIRCULATION RESEARCH (2020)
Protein kinase B/AKT mediates insulin-like growth factor 1-induced phosphorylation and nuclear export of histone deacetylase 5 via NADPH oxidase 4 activation in vascular smooth muscle cells
Paulina Pietruczuk et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2019)
Metabolic Changes in Spontaneously Hypertensive Rat Hearts Precede Cardiac Dysfunction and Left Ventricular Hypertrophy
Jie Li et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2019)
Enhancing fatty acid utilization ameliorates mitochondrial fragmentation and cardiac dysfunction via rebalancing optic atrophy 1 processing in the failing heart
Yongzheng Guo et al.
CARDIOVASCULAR RESEARCH (2018)
Acute and Chronic Effects of Protein Kinase-D Signaling on Cardiac Energy Metabolism
Ozlenen Simsek Papur et al.
FRONTIERS IN CARDIOVASCULAR MEDICINE (2018)
Loss of Metabolic Flexibility in the Failing Heart
Qutuba G. Karwi et al.
FRONTIERS IN CARDIOVASCULAR MEDICINE (2018)
PKD knockdown inhibits pressure overload-induced cardiac hypertrophy by promoting autophagy via AKT/mTOR pathway
Di Zhao et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2017)
Metabolism and acetylation contribute to leucine-mediated inhibition of cardiac glucose uptake
Edith Renguet et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2017)
O-GlcNAcylation, enemy or ally during cardiac hypertrophy development?
Florence Mailleux et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2016)
Remodeling of Glucose Metabolism Precedes Pressure Overload-Induced Left Ventricular Hypertrophy: Review of a Hypothesis
Bijoy K. Kundu et al.
CARDIOLOGY (2015)
Polydatin prevents hypertrophy in phenylephrine induced neonatal mouse cardiomyocytes and pressure-overload mouse models
Ming Dong et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2015)
Hydrogen sulfide improves glucose metabolism and prevents hypertrophy in cardiomyocytes
Min Liang et al.
NITRIC OXIDE-BIOLOGY AND CHEMISTRY (2015)
Cardiac contraction-induced GLUT4 translocation requires dual signaling input
Joost J. F. P. Luiken et al.
TRENDS IN ENDOCRINOLOGY AND METABOLISM (2015)
CD36 inhibition prevents lipid accumulation and contractile dysfunction in rat cardiomyocytes
Yeliz Angin et al.
BIOCHEMICAL JOURNAL (2012)
Cardiac-Specific Deletion of Acetyl CoA Carboxylase 2 Prevents Metabolic Remodeling During Pressure-Overload Hypertrophy
Stephen C. Kolwicz et al.
CIRCULATION RESEARCH (2012)
Agonist-Induced Hypertrophy and Diastolic Dysfunction Are Associated With Selective Reduction in Glucose Oxidation A Metabolic Contribution to Heart Failure With Normal Ejection Fraction
Jun Mori et al.
CIRCULATION-HEART FAILURE (2012)
Protein Kinase D1 Is Essential for Contraction-induced Glucose Uptake but Is Not Involved in Fatty Acid Uptake into Cardiomyocytes
Ellen Dirkx et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Fiji: an open-source platform for biological-image analysis
Johannes Schindelin et al.
NATURE METHODS (2012)
Responses of hypertrophied myocytes to reactive species: implications for glycolysis and electrophile metabolism
Brian E. Sansbury et al.
BIOCHEMICAL JOURNAL (2011)
Modulating fatty acid oxidation in heart failure
Vincenzo Lionetti et al.
CARDIOVASCULAR RESEARCH (2011)
Subcellular trafficking of the substrate transporters GLUT4 and CD36 in cardiomyocytes
Laura K. M. Steinbusch et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2011)
Phosphoinositide-3 Kinase Signaling in Cardiac Hypertrophy and Heart Failure
Toshinori Aoyagi et al.
CURRENT PHARMACEUTICAL DESIGN (2011)
Cellular mechanisms of cardiomyopathy
Pamela A. Harvey et al.
JOURNAL OF CELL BIOLOGY (2011)
AFos inhibits phenylephrine-mediated contractile dysfunction by altering phospholamban phosphorylation
Mark Y. Jeong et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2010)
Return to the fetal gene program A suggested metabolic link to gene expression in the heart
Heinrich Taegtmeyer et al.
ANALYSIS OF CARDIAC DEVELOPMENT: FROM EMBRYO TO OLD AGE (2010)
Requirement for distinct vesicle-associated membrane proteins in insulin- and AMP-activated protein kinase (AMPK)-induced translocation of GLUT4 and CD36 in cultured cardiomyocytes
R. W. Schwenk et al.
DIABETOLOGIA (2010)
Effects of thapsigargin and phenylephrine on calcineurin and protein kinase C signaling functions in cardiac myocytes
Anand Mohan Prasad et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2009)
Protein kinase D in the cardiovascular system - Emerging roles in health and disease
Metin Avkiran et al.
CIRCULATION RESEARCH (2008)
Activation of protein synthesis in cardiomyocytes by the hypertrophic agent phenylephrine requires the activation of ERK and involves phosphorylation of tuberous sclerosis complex 2 (TSC2)
M Rolfe et al.
BIOCHEMICAL JOURNAL (2005)
Hypertrophy of the heart - A new therapeutic target?
N Frey et al.
CIRCULATION (2004)
Cardiac histone acetylation - therapeutic opportunities abound
TA McKinsey et al.
TRENDS IN GENETICS (2004)
Dipyridamole alters cardiac substrate preference by inducing translocation of FAT/CD36, but not that of GLUT4
JJFP Luiken et al.
MOLECULAR PHARMACOLOGY (2004)
Inhibition of glucose uptake in murine cardiomyocyte cell line HL-1 by cardioprotective drugs dilazep and dipyridamole
I Shuralyova et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2004)
Cochrane review: Dipyridamole for preventing major vascular events in patients with vascular disease
ELLM De Schryver et al.
STROKE (2003)
Class II histone deacetylases act as signal-responsive repressors of cardiac hypertrophy
CL Zhang et al.
CELL (2002)
A benefit-risk assessment of agents used in the secondary prevention of stroke
RS MacWalter et al.
DRUG SAFETY (2002)
分享论文
